LEADING THE FIGHT AGAINST NASH/MASH
No family should have to go through the experience of watching a loved one struggle with decompensated cirrhosis or liver transplant due to NASH. That is why we aim to develop therapies that will protect patients, and the health system, by halting and reversing NASH before the devastating complications of cirrhosis occur.
Every team member at Madrigal is dedicated to defeating NASH.
Our focus on patients is at the heart of everything we do
Patients are Madrigal’s collective north star, guiding our work to pursue novel therapeutics for NASH. By prioritizing patients, we put our total focus on providing solutions and treatments for their unmet needs.
Our owner mindset means we are accountable for our promises
To best serve patients, we embrace accountability throughout our team, taking ownership at the individual level. This helps to ensure results that exceed expectations and deliver on our promises.
Our relentless pursuit of innovation transforms hope into reality
We must always strive to think the next great thought, to work through the seemingly unsolvable problem, and embrace new ideas from the outside in – driving innovation and turning our intentions into reality.
Our commitment to collaboration creates a brighter future for patients
Every success is a team effort – a result of an inclusive and collaborative culture, driven by our shared passion to change lives through novel therapeutics.